Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Performance of Birmingham Vasculitis Activity Score and disease extent index in childhood vasculitides.
Demirkaya E, Ozen S, Pistorio A, Galasso R, Ravelli A, Hasija R, Baskin E, Dressler F, Fischbach M, Garcìa Consuegra J, Iagaru N, Pasic S, Scarpato S, van Rossum MA, Apaz MT, Barash J, Calcagno G, Gonzalez B, Hoppenreijs E, Ioseliani M, Mazur-Zielinska H, Vougiouka O, Wulffraat N, Luqmani R, Martini A, Ruperto N, Dolezalova P; Paediatric Rheumatology International Trials Organization (PRINTO). Demirkaya E, et al. Among authors: hoppenreijs e. Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S162-8. Epub 2012 May 14. Clin Exp Rheumatol. 2012. PMID: 22640658
A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis.
van Straalen JW, Giancane G, Amazrhar Y, Tzaribachev N, Lazar C, Uziel Y, Telcharova-Mihaylovska A, Len CA, Miniaci A, Boteanu AL, Filocamo G, Mastri MV, Arkachaisri T, Magnolia MG, Hoppenreijs E, de Roock S, Wulffraat NM, Ruperto N, Swart JF; Paediatric Rheumatology International Trials Organisation (PRINTO). van Straalen JW, et al. Among authors: hoppenreijs e. Rheumatology (Oxford). 2021 Jun 18;60(6):2896-2905. doi: 10.1093/rheumatology/keaa733. Rheumatology (Oxford). 2021. PMID: 33274366 Free PMC article.
Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010.
Otten MH, Prince FH, Twilt M, Ten Cate R, Armbrust W, Hoppenreijs EP, Koopman-Keemink Y, Wulffraat NM, Gorter SL, Dolman KM, Swart JF, van den Berg JM, van Rossum MA, van Suijlekom-Smit LW. Otten MH, et al. J Rheumatol. 2011 Oct;38(10):2258-63. doi: 10.3899/jrheum.110145. Epub 2011 Aug 15. J Rheumatol. 2011. PMID: 21844151
Tumour necrosis factor-blocking agents in persistent oligoarticular juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children Register.
Anink J, Otten MH, Prince FH, Hoppenreijs EP, Wulffraat NM, Swart JF, ten Cate R, van Rossum MA, van den Berg JM, Dolman KM, Koopman-Keemink Y, Armbrust W, Kamphuis S, van Pelt PA, Gorter SL, van Suijlekom-Smit LW. Anink J, et al. Rheumatology (Oxford). 2013 Apr;52(4):712-7. doi: 10.1093/rheumatology/kes373. Epub 2012 Dec 24. Rheumatology (Oxford). 2013. PMID: 23267169
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry.
Ter Haar NM, Jeyaratnam J, Lachmann HJ, Simon A, Brogan PA, Doglio M, Cattalini M, Anton J, Modesto C, Quartier P, Hoppenreijs E, Martino S, Insalaco A, Cantarini L, Lepore L, Alessio M, Calvo Penades I, Boros C, Consolini R, Rigante D, Russo R, Pachlopnik Schmid J, Lane T, Martini A, Ruperto N, Frenkel J, Gattorno M; Paediatric Rheumatology International Trials Organisation and Eurofever Project. Ter Haar NM, et al. Among authors: hoppenreijs e. Arthritis Rheumatol. 2016 Nov;68(11):2795-2805. doi: 10.1002/art.39763. Arthritis Rheumatol. 2016. PMID: 27213830 Free article.
Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?
Anink J, Otten MH, Gorter SL, Prince FH, van Rossum MA, van den Berg JM, van Pelt PA, Kamphuis S, Brinkman DM, Swen WA, Swart JF, Wulffraat NM, Dolman KM, Koopman-Keemink Y, Hoppenreijs EP, Armbrust W, ten Cate R, van Suijlekom-Smit LW. Anink J, et al. Rheumatology (Oxford). 2013 Sep;52(9):1674-9. doi: 10.1093/rheumatology/ket170. Epub 2013 Jun 4. Rheumatology (Oxford). 2013. PMID: 23740187
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
Prince FH, Twilt M, ten Cate R, van Rossum MA, Armbrust W, Hoppenreijs EP, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat NM, van Suijlekom-Smit LW. Prince FH, et al. Among authors: hoppenreijs ep. Ann Rheum Dis. 2009 May;68(5):635-41. doi: 10.1136/ard.2007.087411. Epub 2008 Apr 15. Ann Rheum Dis. 2009. PMID: 18413443 Clinical Trial.
Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?
Otten MH, Prince FH, Ten Cate R, van Rossum MA, Twilt M, Hoppenreijs EP, Koopman-Keemink Y, Oranje AP, de Waard-van der Spek FB, Gorter SL, Armbrust W, Dolman KM, Wulffraat NM, van Suijlekom-Smit LW. Otten MH, et al. Ann Rheum Dis. 2011 Feb;70(2):337-40. doi: 10.1136/ard.2010.135731. Epub 2010 Nov 10. Ann Rheum Dis. 2011. PMID: 21068101 Clinical Trial.
66 results